References

Predicting diagnostic outcome in adult autism spectrum disorder using the autism diagnostic observation schedule, second edition

10.1186/s12888-020-03028-7 · 2021 · External reference

The multifaceted role of L-type amino acid transporter 1 at the blood-brain barrier: structural implications and therapeutic potential

10.1007/s12035-024-04506-9 · 2025 · External reference

Phenylalanine and tryptophan intake of hyperactive children with autism

10.14710/jbtr.v3i2.1744 · 2017 · External reference

Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments

10.3389/fpsyt.2019.00561 · 2019 · External reference

Inborn error metabolic screening in individuals with nonsyndromic autism spectrum disorders

10.1111/dmcn.13114 · 2016 · External reference

Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder

10.1038/s41598-024-54717-2 · 2024 · External reference

Biological variation of free plasma amino acids in healthy individuals

10.1515/cclm.2010.008 · 2010 · External reference

Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders

10.1016/j.cell.2019.11.020 · 2019 · External reference

The relationship between the childhood autism rating scale: second edition and clinical diagnosis utilizing the DSM-IV-TR and the DSM-5

10.1007/s10803-016-2860-z · 2016 · External reference

Unresolved reference

2026 · External reference

Versatile triad alliance: bile acid, taurine and microbiota

10.3390/cells11152337 · 2022 · External reference

Amino acid patterns in children with autistic Spectrum disorder: a preliminary biochemical evaluation

10.3390/nu17020274 · 2025 · External reference

Standardizing ADOS scores for a measure of severity in autism spectrum disorders

10.1007/s10803-008-0674-3 · 2009 · External reference

Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson’s disease

10.1016/0024-3205(82)90596-3 · 1982 · External reference

Review: microbial transformations of human bile acids

10.1186/s40168-021-01101-1 · 2021 · External reference

GABA and glutamate in children with primary complex motor stereotypies: an 1H-MRS study at 7T

10.3174/ajnr.a4547 · 2016 · External reference

Autism Spectrum disorder: a review

10.1001/jama.2022.23661 · 2023 · External reference

The continuing importance of bile acids in liver and intestinal disease

10.1001/archinte.159.22.2647 · 1999 · External reference

Council on Children with Disabilities Section on Developmental and behavioral pediatrics identification, evaluation, and management of children with autism spectrum disorder

10.1542/peds.2019-3447 · 2020 · External reference

Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism

10.1093/ajcn/80.6.1611 · 2004 · External reference

People are different: tyrosine’s modulating effect on cognitive control in healthy humans may depend on individual differences related to dopamine function

10.3389/fpsyg.2014.01101 · 2014 · External reference

The promise of precision medicine in autism

10.1016/j.neuron.2021.06.025 · 2021 · External reference

Effectiveness of N-acetylcysteine in autism spectrum disorders: a meta-analysis of randomized controlled trials

10.1177/0004867420952540 · 2021 · External reference

Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress

10.1016/s1665-2681(19)31785-5 · 2009 · External reference

Associations between amino acid levels and autism spectrum disorder severity

10.1186/s12888-025-06771-x · 2025 · External reference

Unresolved reference

2026 · External reference

Unresolved reference

2012 · External reference

Prevalence and characteristics of autism Spectrum disorder among children aged 8 years - autism and developmental Disabilities monitoring network, 11 sites, United States, 2020

10.15585/mmwr.ss7202a1 · 2023 · External reference

Balancing act: maintaining amino acid levels in the autistic brain

10.1016/j.neuron.2017.01.015 · 2017 · External reference

Test review: autism diagnostic observation schedule, second edition (ADOS-2) manual (part II): toddler module

2014 · External reference

Plasma and fecal metabolite profiles in autism Spectrum disorder

10.1016/j.biopsych.2020.09.025 · 2021 · External reference

The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment

10.1007/s00702-014-1216-0 · 2014 · External reference

Insights into autism Spectrum disorder genomic architecture and biology from 71 risk loci

10.1016/j.neuron.2015.09.016 · 2015 · External reference

Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?

10.1371/journal.pone.0021932 · 2011 · External reference

Amino acid dysregulation Metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism Spectrum disorder

10.1016/j.biopsych.2018.08.016 · 2019 · External reference

Comparison of liquid chromatography with tandem mass spectrometry and ion-exchange chromatography by post-column ninhydrin derivatization for amino acid monitoring

10.1016/j.cca.2019.05.007 · 2019 · External reference

Altered metabolic characteristics in plasma of young boys with autism Spectrum disorder

10.1007/s10803-021-05364-3 · 2022 · External reference

Unresolved reference

2021 · External reference

Comparison of serum B12, folate and homocysteine concentrations in children with autism spectrum disorder or attention deficit hyperactivity disorder and healthy controls

10.2147/ndt.s212361 · 2019 · External reference

The objectivity of the autism diagnostic observation schedule (ADOS) in naturalistic clinical settings

10.1007/s00787-015-0793-2 · 2016 · External reference

Blood glutamate levels in autism Spectrum disorder: a systematic review and Meta-analysis

10.1371/journal.pone.0158688 · 2016 · External reference

Novel aspects of glutamine synthetase in ammonia homeostasis

10.1016/j.neuint.2020.104809 · 2020 · External reference

Inborn errors of metabolism associated with autism Spectrum disorders: approaches to intervention

10.3389/fnins.2021.673600 · 2021 · External reference

Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons

10.1016/j.neuint.2009.12.021 · 2010 · External reference